Method for treating multiple sclerosis
US5958409A · kind A · utility
13Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 1996 |
| Grant date | Sep 28, 1999 |
| Priority date | — |
| Expiry date | Mar 13, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating multiple sclerosis, through the administration of anti-tumour necrosis factor antibody, of soluble tumour necrosis factor receptor or of a compound capable of blocking tumour necrosis factor production, its effects and/or tumour necrosis factor receptor signal transduction, is disclosed. The method can be used to aid in therapy for humans and other mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.